Therefore, this is the first study to show that migration inhibition of bone marrow cells by CXCR4 shRNA inhibits development of hypoxia-induced pulmonary hypertension and vascular remodeling. This evidence concerns the gene CXCR4 and pulmonary arterial hypertension.